Depression and Buprenorphine Treatment in Patients with Non-cancer Pain and Prescription Opioid Dependence without Comorbid Substance Use Disorders

Changes in substance use in patients receiving opioid substitution therapy and resulting clinical challenges: a 17-year treatment case register analysis

Lancet Psychiatry.

Herdener M, Dürsteler KM, Seifritz E, Nordt C

doi: 10.1016/S2215-0366

Anxiety and Depression

Moderating effect of comorbid anxiety disorders on treatment outcome in a randomized controlled psychotherapy trial in early-onset persistently depressed outpatients

Depress Anxiety.

Assmann N, Schramm E, Kriston L, Hautzinger M, Härter M, Schweiger U, Klein JP

doi: 10.1002/da.22839.

Bipolar Disorder

Effects of psychotherapy on comorbid bipolar disorder and substance use disorder: a systematic review

Bipolar Disord.

Crowe M, Eggleston K, Douglas K, Porter RJ

doi: 10.1111/bdi.12971.

Anxiety and Depression

Anxiety, Depression, and Insomnia Among Adults With Opioid Dependence Treated With Extended-Release Naltrexone vs Buprenorphine-Naloxone: A Randomized Clinical Trial and Follow-up Study

JAMA Psychiatry.

Latif ZE, Šaltyte Benth J, Solli KK, Opheim A, Kunoe N, Krajci P, Sharma-Haase K, Tanum L

doi: 10.1001/jamapsychiatry.

Further Publications Psychiatry

Antidepressant treatment outcomes in patients with and without comorbid physical or psychiatric disorders: A systematic review and meta-analysis

J Affect Disord

Kim HK, Blumberger DM, Fitzgerald PB, Mulsant BH, Daskalakis ZJ

doi: 10.1016/j.jad.2021.08.046

Autism

Risk of Substance Use Disorder and Its Associations With Comorbidities and Psychotropic Agents in Patients With Autism

JAMA Pediatr

Huang JS, Yang FC, Chien WC, Yeh TC, Chung CH, Tsai CK, Tsai SJ, Yang SS, Tzeng NS, Chen MH, Liang CS

doi: 10.1001/jamapediatrics.2020.5371

Bipolar Disorder

Tobacco smoking and other substance use disorders associated with recurrent suicide attempts in bipolar disorder

J Affect Disord.

Icick R, Melle I, Etain B, Ringen PA, Aminoff SR, Leboyer M, Aas M, Henry C, Bjella TD, Andreassen OA, Bellivier F, Lagerberg TV

doi: 10.1016/j.jad.2019.05.075.

Anxiety and Depression

Longitudinal study of impact of medication for opioid use disorder on Hamilton Depression Rating Scale

J Affect Disord

Wang K, DiChiacchio T, Fang W, Lander L, Feinberg J, Xie C, Winstanley EL, Ubolrat Piamjariyakul

doi: 10.1016/j.jad.2021.10.018

Anxiety and DepressionBipolar Disorder

Long-term use of lurasidone in patients with bipolar disorder: safety and effectiveness over 2 years of treatment

Int J Bipolar Disord.

Pikalov A, Tsai J, Mao Y, Silva R, Cucchiaro J, Loebel A

doi: 10.1186/

Related content

Changes in substance use in patients receiving opioid substitution therapy and resulting clinical challenges: a 17-year treatment case register analysis

Moderating effect of comorbid anxiety disorders on treatment outcome in a randomized controlled psychotherapy trial in early-onset persistently depressed outpatients

Effects of psychotherapy on comorbid bipolar disorder and substance use disorder: a systematic review

Anxiety, Depression, and Insomnia Among Adults With Opioid Dependence Treated With Extended-Release Naltrexone vs Buprenorphine-Naloxone: A Randomized Clinical Trial and Follow-up Study

Antidepressant treatment outcomes in patients with and without comorbid physical or psychiatric disorders: A systematic review and meta-analysis

Risk of Substance Use Disorder and Its Associations With Comorbidities and Psychotropic Agents in Patients With Autism

Tobacco smoking and other substance use disorders associated with recurrent suicide attempts in bipolar disorder

Longitudinal study of impact of medication for opioid use disorder on Hamilton Depression Rating Scale

Long-term use of lurasidone in patients with bipolar disorder: safety and effectiveness over 2 years of treatment